News & Events

Alper Biotech is a biotechnology company focused on:

•  identification of unique proprietary cancer biomarker proteins
•  development of highly-specific monoclonal antibodies to detect unique protein targets

We are committed to developing a portfolio of monoclonal antibody-based diagnostic assays to identify unique cancer proteins in both tissue and blood. Our antibodies are selected to help address unmet medical needs in managing cancer diagnosis and therapy today. These assays may be useful for prognosis, diagnosis, managing therapy, and screening/detection in various cancers.

Alper Biotech is a biotechnology company specializing in the identification, development and commercialization of novel highly-specific monoclonal antibody-based diagnostic assays in cancer.

Alper's monoclonal antibodies uniquely recognize proteins that are modified and differentially expressed in cancer cells. This novel and proprietary approach to cancer diagnostics will be applied to a variety of search and clinical testing applications.
Alper's pipeline of cancer diagnostic kits will cover many tumor types starting with breast cancer and expanding into other tumors of major concern to Oncologists. Alper's monoclonal antibodies are selected to help address high unmet medical needs in managing cancer diagnosis and therapy today.